Početna › Multipla skleroza › Michigan
Kliničke studije za Multipla skleroza u državi Michigan
10 studija za Multipla skleroza traži sudionike na lokacijama u državi Michigan.
Gradovi u državi Michigan
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Northwest Neurology, Southfield
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06782490A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Ann Arbor
- TG Therapeutics Investigational Trial Site, Detroit
- TG Therapeutics Investigational Trial Site, Farmington
- i još 2
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Michigan Institute for Neurological Disorders- Site Number : 8400004, Farmington Hills
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07325292A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06680037Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- Kahana Oculoplastic and Orbital Surgery, Livonia
U tijeku regrutacijaFaza 3
Od 18 do 50 godina · Oba spola · Ažurirano 14. kol 2026. · NCT07623668A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Michigan Institute of Neurological, Farmington Hills
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07225504Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
- University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 17. srp 2026. · NCT05269628A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- Quest Research Institute, Farmington Hills
U tijeku regrutacijaFaza 2
Od 18 do 55 godina · Oba spola · Ažurirano 15. lip 2026. · NCT06735248Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
- Wayne State University, Detroit
U tijeku regrutacijaOpažajna studija
Od 18 do 60 godina · Oba spola · Ažurirano 6. lip 2022. · NCT04458688Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.